Bixiye
P64-17 New Drug-Related PA with Quantity Limit Criteria: Biologic Immunomodulators
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Natiijooyinka Raadinta
Soo bandhiga 3261 - 3270 ee natiijooyinka 4744
Bixiye
P68-17 Reimbursement Rate Changes for Psychotherapy Codes 90837 and 90838
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2017
Bixiye
P30-17 New Drug-Related Prior Authorization (PA) Criteria: Topical Retinoids
Taariikhda wax ku ool ah ee barnaamijka: Jun 05, 2017
Bixiye
P41-18 Update: Change to TPA Business
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 04, 2018
Bixiye
P46-17 Addition of Drug to the Self-Administered Oncology PA with Quantity Limit Program
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Bixiye
P12-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective June 4, 2018
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
P10-18 Blue Cross Will Cease Mailing Certain Provider Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2018
Bixiye
P19R1-17 New Remittance Code: OA-45 for Purchased/Referred (PRC)-Eligible Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
P8-18 Changes to PA for Hip Arthroplasty, Hip Resurfacing and Knee Arthroplasty for Commercial and Government Programs Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2018
Bixiye
P78-17 Cotiviti to Perform Inpatient Claims Reviews
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2017